BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,754,000 | +7.3% | 71,140 | +3.4% | 0.02% | +20.0% |
| Q2 2022 | $10,026,000 | +26.2% | 68,810 | +2.2% | 0.02% | +50.0% |
| Q1 2022 | $7,946,000 | +28.2% | 67,324 | +49.7% | 0.01% | +25.0% |
| Q4 2021 | $6,199,000 | -31.2% | 44,985 | -30.6% | 0.01% | -42.9% |
| Q3 2021 | $9,007,000 | +25.0% | 64,841 | -12.6% | 0.01% | +55.6% |
| Q2 2021 | $7,205,000 | +95.5% | 74,215 | +37.6% | 0.01% | +80.0% |
| Q1 2021 | $3,686,000 | -51.8% | 53,928 | -39.6% | 0.01% | 0.0% |
| Q4 2020 | $7,650,000 | +127.8% | 89,262 | +72.9% | 0.01% | 0.0% |
| Q3 2020 | $3,358,000 | -2.8% | 51,613 | +9.2% | 0.01% | -16.7% |
| Q2 2020 | $3,455,000 | +348.7% | 47,258 | +96.8% | 0.01% | +200.0% |
| Q1 2020 | $770,000 | -53.5% | 24,010 | -21.1% | 0.00% | -33.3% |
| Q4 2019 | $1,657,000 | – | 30,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |